South Korea Benign Prostatic Hyperplasia (BPH) Market Insight
Published: 16 June 2026 | Report Format: Electronic (PDF)
The South Korea benign prostatic hyperplasia (bph) market will grow at a rate of 7.48% owing to the increasing aging male population, rising prevalence of prostate disorders, growing awareness regarding early diagnosis, and increasing adoption of minimally invasive treatment procedures and advanced urological technologies
South Korea Benign Prostatic Hyperplasia (BPH) Market Insights Forecasts to 2035
- The South Korea Benign Prostatic Hyperplasia (BPH) Market Size Was Estimated USD 17.6 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.48% from 2025 to 2035
- The South Korea Benign Prostatic Hyperplasia (BPH) Market Size is Expected to Rise Around USD 36.2 Million by 2035
Notable Insights for the South Korea Benign Prostatic Hyperplasia (BPH) Market
- Segmentation on the basis of Treatment Type indicates that Laser Therapy Systems segment holds the dominant position in the South Korea Benign Prostatic Hyperplasia Market in 2025 with a market share of nearly 56% due to increasing preference for effective procedures with faster patient recovery.
- Segmentation on the basis of Application indicates that Hospital-Based Urology Treatments segment holds the dominant position in the South Korea Benign Prostatic Hyperplasia Market in 2025 with a market share of around 60% due to growing patient volume.
- World-wide projected revenue of Boston Scientific Corporation in fiscal year 2025 would be around USD 17 billion owing to strong demand for urology treatment devices, minimally invasive technologies.
- It is expected that increasing adoption of laser-assisted treatment systems, where modern BPH treatment solutions improve procedural efficiency by up to 40% and reduce hospitalization periods by up to 32%
Download the eBook (ToC)
Why Buy This Report
- Gives an in-depth analysis of the impact of aging demographics, increasing prevalence of prostate enlargement disorders, and advancements in minimally invasive urology procedures on the South Korea Benign Prostatic Hyperplasia Market growth.
- Provides strategic insights regarding technology innovation such as laser-based prostate treatment systems, AI-assisted diagnostic technologies, real-time surgical imaging platforms, and advanced endoscopic treatment solutions.
- Assists players to analyze competitive benchmarking, investments in urology care infrastructure, adoption of innovative treatment technologies, and expansion opportunities by major healthcare and medical device companies.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Benign Prostatic Hyperplasia Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Benign Prostatic Hyperplasia Market
- Boston Scientific Corporation
- Olympus Corporation
- Lumenis Ltd.
- KARL STORZ SE & Co. KG
- Richard Wolf GmbH
- Coloplast A/S
- Cook Medical
- Asclepion Laser Technologies GmbH
- Biolitec AG
- Teleflex Incorporated
Recent Developments:
- In October 2025, Boston Scientific Corporation expanded its minimally invasive BPH treatment portfolio with advanced laser-based technologies designed to improve procedural outcomes and patient recovery rates
- In July 2025, Olympus Corporation introduced next-generation urology imaging and treatment platforms to enhance precision during BPH diagnosis and surgical interventions.
Market Segmentation:
South Korea Benign Prostatic Hyperplasia (BPH) Market, By Treatment Type
- Laser Therapy Systems
- Drug Therapy
- Minimally Invasive Surgical Treatments
- Transurethral Resection Procedures
- Other Urology Treatment Solutions
South Korea Benign Prostatic Hyperplasia (BPH) Market, By Technology
- AI-Based Diagnostic Platforms
- Laser-Assisted Treatment Technologies
- Endoscopic Surgical Systems
- Real-Time Imaging Solutions
- Advanced Urology Monitoring Systems
South Korea Benign Prostatic Hyperplasia (BPH) Market, By Application
- Hospital-Based Urology Treatments
- Specialty Urology Centers
- Ambulatory Surgical Centers
- Diagnostic Clinics
- Academic & Research Institutions
Expert Views:
The South Korea Benign Prostatic Hyperplasia Market will grow owing to the increasing prevalence of prostate enlargement disorders, rising healthcare expenditure, and growing preference for minimally invasive treatment procedures. The inclusion of advanced laser therapy systems, AI-assisted diagnostics, endoscopic surgical technologies, and real-time imaging platforms will improve treatment outcomes and operational efficiency, driving demand across hospitals, specialty urology centers, and advanced healthcare facilities through 2035
Author: Aditi and Govind By Decisions Advisors and Consulting